BamSEC and AlphaSense Join Forces
Learn More

Tourmaline Bio Inc.

NASDAQ: TRML    
Share price (12/23/24): $21.30    
Market cap (12/23/24): $546 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.10
from S-3 19 pages Tourmaline Bio, Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of Tourmaline Bio, Inc. Form of Debt Securities Warrant Agreement
12/34/56
EX-4.9
from S-3 21 pages Tourmaline Bio, Inc. and , as Warrant Agent Form of Preferred Stock Warrant Agreement Dated as of Tourmaline Bio, Inc. Form of Preferred Stock Warrant Agreement
12/34/56
EX-4.8
from S-3 20 pages Tourmaline Bio, Inc. and , as Warrant Agent Form of Common Stock Warrant Agreement Dated as of Tourmaline Bio, Inc. Form of Common Stock Warrant Agreement
12/34/56
EX-4.5
from S-3 45 pages Tourmaline Bio, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [●], 20__ Debt Securities Indenture
12/34/56
EX-4.2
from 10-K 4 pages Description of Securities
12/34/56
EX-4.1
from 10-K 3 pages Indenture or similar
12/34/56
EX-4.6
from S-3 40 pages Talaris Therapeutics, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [•], 202[•] Subordinated Debt Securities
12/34/56
EX-4.5
from S-3 39 pages Talaris Therapeutics, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [●], 202[●] Senior Debt Securities
12/34/56
EX-4.3
from 10-K 6 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.2
from S-1 27 pages Amended and Restated Investors’ Rights Agreement
12/34/56
EX-4.1
from S-1 2 pages Indenture or similar
12/34/56
EX-4.2
from DRS 27 pages Amended and Restated Investors’ Rights Agreement
12/34/56